These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19199480

  • 1. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
    Vu CB, Bemis JE, Disch JS, Ng PY, Nunes JJ, Milne JC, Carney DP, Lynch AV, Smith JJ, Lavu S, Lambert PD, Gagne DJ, Jirousek MR, Schenk S, Olefsky JM, Perni RB.
    J Med Chem; 2009 Mar 12; 52(5):1275-83. PubMed ID: 19199480
    [Abstract] [Full Text] [Related]

  • 2. Identification of a new class of glucokinase activators through structure-based design.
    Hinklin RJ, Boyd SA, Chicarelli MJ, Condroski KR, DeWolf WE, Lee PA, Lee W, Singh A, Thomas L, Voegtli WC, Williams L, Aicher TD.
    J Med Chem; 2013 Oct 10; 56(19):7669-78. PubMed ID: 24015910
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives.
    Andreani A, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Roda A.
    Eur J Med Chem; 2005 Dec 10; 40(12):1331-4. PubMed ID: 16129518
    [Abstract] [Full Text] [Related]

  • 4. Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
    Pawar PY, Bhise SB.
    Indian J Physiol Pharmacol; 2006 Dec 10; 50(4):431-4. PubMed ID: 17402276
    [No Abstract] [Full Text] [Related]

  • 5. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.
    Andreani A, Burnelli S, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Rizzoli M, Varoli L, Roda A.
    Eur J Med Chem; 2008 Mar 10; 43(3):657-61. PubMed ID: 17624631
    [Abstract] [Full Text] [Related]

  • 6. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
    Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Lenaz G, Fato R, Bergamini C, Farruggia G.
    J Med Chem; 2005 Apr 21; 48(8):3085-9. PubMed ID: 15828848
    [Abstract] [Full Text] [Related]

  • 7. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
    Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Calonghi N, Cappadone C, Farruggia G, Zini M, Stefanelli C, Masotti L, Radin NS, Shoemaker RH.
    J Med Chem; 2008 Feb 28; 51(4):809-16. PubMed ID: 18251494
    [Abstract] [Full Text] [Related]

  • 8. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
    Aicher TD, Balkan B, Bell PA, Brand LJ, Cheon SH, Deems RO, Fell JB, Fillers WS, Fraser JD, Gao J, Knorr DC, Kahle GG, Leone CL, Nadelson J, Simpson R, Smith HC.
    J Med Chem; 1998 Nov 05; 41(23):4556-66. PubMed ID: 9804695
    [Abstract] [Full Text] [Related]

  • 9. Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.
    de Nanteuil G, Herve Y, Duhault J, Espinal J, Boulanger M, Ravel D.
    Arzneimittelforschung; 1995 Nov 05; 45(11):1176-81. PubMed ID: 8929235
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
    Crane L, Anastassiadou M, El Hage S, Stigliani JL, Baziard-Mouysset G, Payard M, Leger JM, Bizot-Espiard JG, Ktorza A, Caignard DH, Renard P.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7419-33. PubMed ID: 16889967
    [Abstract] [Full Text] [Related]

  • 11. Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.
    Kitas E, Mohr P, Kuhn B, Hebeisen P, Wessel HP, Haap W, Ruf A, Benz J, Joseph C, Huber W, Sanchez RA, Paehler A, Benardeau A, Gubler M, Schott B, Tozzo E.
    Bioorg Med Chem Lett; 2010 Jan 15; 20(2):594-9. PubMed ID: 19969452
    [Abstract] [Full Text] [Related]

  • 12. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS, Belair L, Guay J, Murgasva R, Sturkenboom W, Ramtohul YK, Zhang L, Huang Z.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5214-7. PubMed ID: 19632834
    [Abstract] [Full Text] [Related]

  • 13. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
    Wrobel J, Li Z, Dietrich A, McCaleb M, Mihan B, Sredy J, Sullivan D.
    J Med Chem; 1998 Mar 26; 41(7):1084-91. PubMed ID: 9544208
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and anthelmintic activity of carbamates derived from imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b]thiazole.
    Marin A, Valls N, Berenguer FJ, Alonso MT, Ramon Martinez A, Mercedes Martinez M, Elguero J.
    Farmaco; 1992 Jan 26; 47(1):63-75. PubMed ID: 1616578
    [Abstract] [Full Text] [Related]

  • 15. Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
    Dang Q, Liu Y, Cashion DK, Kasibhatla SR, Jiang T, Taplin F, Jacintho JD, Li H, Sun Z, Fan Y, DaRe J, Tian F, Li W, Gibson T, Lemus R, van Poelje PD, Potter SC, Erion MD.
    J Med Chem; 2011 Jan 13; 54(1):153-65. PubMed ID: 21126019
    [Abstract] [Full Text] [Related]

  • 16. [Imidazo(2,1-b)thiazole XII derivatives. Synthesis and research of immunoactivity in vitro on human T lymphocyte of 3-aroylmethyl and 2-aroyl-3-methyl(aryl)-5,6-dihydroimidaz o(2,1-b)thiazoles].
    Robert JF, Hassanine A, Harraga S, Seilles E.
    Ann Pharm Fr; 1995 Jan 13; 53(6):261-71. PubMed ID: 8572506
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R, Ioan P, Locatelli A, Cosconati S, Leoni A, Ugenti MP, Andreani A, Di Toro R, Bedini A, Spampinato S, Marinelli L, Novellino E, Chiarini A.
    J Med Chem; 2008 Mar 27; 51(6):1592-600. PubMed ID: 18303827
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.